HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Amy Hauck Newman Selected Research

Amy Hauck Newman Research Topics

Disease

22Substance-Related Disorders (Drug Abuse)
05/2022 - 06/2005
17Cocaine-Related Disorders (Cocaine Addiction)
12/2019 - 05/2002
10Opioid-Related Disorders (Opiate Addiction)
05/2022 - 01/2016
4Parkinson Disease (Parkinson's Disease)
07/2015 - 04/2007
3Dyskinesias (Dyskinesia)
02/2019 - 05/2009
2Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
10/2020 - 09/2012
2Mental Disorders (Mental Disorder)
08/2020 - 10/2013
2Pain (Aches)
11/2019 - 06/2009
2Restless Legs Syndrome (Restless Legs)
07/2015 - 01/2014
2Schizophrenia (Dementia Praecox)
07/2015 - 01/2014
2Nervous System Diseases (Neurological Disorders)
07/2015 - 01/2014
2Sleep Wake Disorders
06/2015 - 10/2013
2Hypothermia
05/2008 - 08/2007
1Catalepsy
10/2021
1Dystonia (Limb Dystonia)
04/2021
1Parkinsonian Disorders (Parkinsonism)
04/2021
1Proteostasis Deficiencies
04/2021
1Ventricular Tachycardia
01/2021
1Cognitive Dysfunction
07/2020
1Alcoholism (Alcohol Abuse)
11/2019
1Opiate Overdose
11/2019
1Tobacco Use Disorder (Nicotine Dependence)
11/2019
1Narcolepsy
10/2013
1Intellectual Disability (Idiocy)
06/2009
1Psychotic Disorders (Schizoaffective Disorder)
04/2007

Drug/Important Bio-Agent (IBA)

18Dopamine D3 ReceptorsIBA
01/2020 - 06/2005
11Cocaine (Cocaine HCl)IBA
05/2022 - 09/2002
8LigandsIBA
10/2021 - 05/2002
7Dopamine (Intropin)FDA LinkGeneric
05/2022 - 08/2007
7Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
04/2021 - 09/2002
7Pharmaceutical PreparationsIBA
10/2020 - 09/2002
5Opioid Analgesics (Opioids)IBA
10/2021 - 11/2017
4N- (4- (4- (2,3- dichlorophenyl)piperazin- 1- yl)but- 2- enyl)- 4- pyridine- 2- ylbenzamideIBA
10/2021 - 08/2007
4Dopamine Receptors (Dopamine Receptor)IBA
10/2020 - 05/2009
4Modafinil (Provigil)FDA Link
08/2017 - 09/2012
4Dopamine Uptake Inhibitors (Dopamine Reuptake Inhibitors)IBA
01/2008 - 09/2002
3VK4-116IBA
05/2022 - 01/2019
3R-VK4-40IBA
05/2022 - 11/2019
3Benztropine (Benzatropine)FDA LinkGeneric
01/2008 - 09/2002
2Oxycodone (Oxycontin)FDA LinkGeneric
05/2022 - 11/2017
2Proteins (Proteins, Gene)FDA Link
04/2021 - 02/2019
2Methamphetamine (Desoxyn)FDA LinkGeneric
07/2020 - 10/2012
2Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
07/2012 - 06/2009
2Levodopa (L Dopa)FDA LinkGeneric
02/2011 - 05/2009
2NGB 2904IBA
05/2007 - 07/2006
1Morphine (MS Contin)FDA LinkGeneric
10/2021
1Mutant Proteins (Protein, Mutant)IBA
04/2021
1Ibogaine (Endabuse)IBA
04/2021
1noribogaineIBA
04/2021
1Potassium Channels (Potassium Channel)IBA
01/2021
1Ether (Diethyl Ether)IBA
01/2021
1Naltrexone (ReVia)FDA LinkGeneric
11/2019
1Naloxone (Narcan)FDA LinkGeneric
11/2019
1Methadone (Dolophine)FDA LinkGeneric
11/2019
1NicotineFDA Link
11/2019
1Buprenorphine (Subutex)FDA LinkGeneric
11/2019
1Varenicline (Chantix)FDA Link
11/2019
1CAB2-015IBA
11/2017
1BAK4-54IBA
11/2017
1N- (2- ((bis(4- fluorophenyl)methyl)thio)ethyl)- 3- phenylpropan- 1- amineIBA
08/2017
1eticloprideIBA
01/2016
1Nootropic Agents (Nootropics)IBA
10/2013
1fenobamIBA
09/2013
1Sulfates (Sulfates, Inorganic)IBA
09/2013
1Adenylyl Cyclases (Adenylyl Cyclase)IBA
02/2011
1N- (4- (4- (2,3- dichlorophenyl)piperazin- 1- yl)butyl)- 4- (pyridin- 3- yl)benzamideIBA
02/2011
1SK&F 81297IBA
05/2009
1Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
05/2008
1Pramipexole (Mirapex)FDA LinkGeneric
05/2008
1vanoxerine (I 893)IBA
01/2008
1pyridineIBA
08/2007
1U 95666EIBA
08/2007
1fluoreneIBA
05/2007
1N- (4- (4- (2,3- dichlorophenyl)piperazin- 1- yl)butyl)- 4- (pyridin- 2- yl)benzamideIBA
05/2007
1benzamideIBA
05/2007
1rimcazoleIBA
09/2002
1Cholinergic Agents (Cholinergics)IBA
05/2002

Therapy/Procedure

5Self Administration (Administration, Self)
07/2020 - 07/2006
3Therapeutics
11/2019 - 09/2002
2Drug Therapy (Chemotherapy)
01/2019 - 09/2009
1Analgesia
10/2021
1Nicotine Replacement Therapy
11/2019
1Induced Hypothermia
08/2007